Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer

Masayuki Hiraki(Osaka Gakuin University), Donald Küfe(Harvard University)
Signal Transduction and Targeted Therapy
May 8, 2018
Cited by 64


Related Papers